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Staphylococcus aureus USA300 represents the dominant community-associated methicillin-resistant S. aureus lineage in the
USA, where it is a major cause of skin and soft tissue infections. Previous comparative genomic studies have described the pop-
ulation structure and evolution of USA300 based on geographically restricted isolate collections. Here, we investigated the
USA300 population by sequencing genomes of a geographically distributed panel of 191 clinical S. aureus isolates belonging
to clonal complex 8 (CC8), derived from the Tigecycline Evaluation and Surveillance Trial program. Isolates were collected at 12
healthcare centres across nine USA states in 2004, 2009 or 2010. Reconstruction of evolutionary relationships revealed that
CC8 was dominated by USA300 isolates (154/191, 81 %), which were heterogeneous and demonstrated limited phylogeo-
graphic clustering. Analysis of the USA300 core genomes revealed an increase in median pairwise SNP distance from 62 to 98
between 2004 and 2010, with a stable pattern of above average dN/dS ratios. The phylogeny of the USA300 population indi-
cated that early diversification events led to the formation of nested clades, which arose through cumulative acquisition of pre-
dominantly non-synonymous SNPs in various coding sequences. The accessory genome of USA300 was largely homogenous
and consisted of elements previously associated with this lineage. We observed an emergence of SCCmec negative and
ACME negative USA300 isolates amongst more recent samples, and an increase in the prevalence of fSa5 prophage.
Together, the analysed S. aureus USA300 collection revealed an evolving pan-genome through increased core genome hetero-
geneity and temporal variation in the frequency of certain accessory elements.
Keywords: MRSA; USA300; Evolution.
Abbreviations: ACME, arginine catabolic mobile element; CA-MRSA, community-associated methicillin-resistant
Staphylococcus aureus; CC, clonal complex; CDS, coding DNA sequence; HA-MRSA, hospital-associated methicillin-
resistant Staphylococcus aureus; HC, healthcare centre; ICE6013, integrative conjugative element 6013; MAD, median
absolute deviation; MGE, mobile genetic element; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-
susceptible Staphylococcus aureus; SaPI, staphylococcal pathogenicity island; SCCmec, Staphylococcal Cassette
Chromosome mec; SNP, single nucleotide polymorphism; SLV, single locus variant; ST, sequence type; T.E.S.T., Tigecycline
Evaluation and Surveillance Trial.
Data statement: All supporting data, code and protocols have been provided within the article or through supplementary
data files.
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deposited in the European Nucleotide Archive. The acces-
sion numbers together with related metadata are provided
in Table S1 (available in the online Supplementary
Material).
Introduction
Staphylococcus aureus is a major cause of human disease
worldwide. One of the most successful lineages of this bac-
terial species is clonal complex 8 (CC8), from which a
number of major methicillin-resistant S. aureus (MRSA)
clones have emerged (Deurenberg & Stobberingh, 2008).
This includes several pandemic MRSA clones associated
with causing healthcare-associated (HA) infections as well
as community-associated (CA) infections (Monecke et al.,
2011). HA-MRSA CC8 clones include historic Archaic and
Iberian clones as well as the more contemporaneous
USA500 clone, whereas the current USA300 epidemic clone
has emerged as the dominant cause of CA infections in the
USA.
The first reports of USA300 date back to the early 2000s,
when it was identified in a number of localised outbreaks of
CA skin and soft-tissue infections (SSTI) (CDC, 2001, 2003,
McDougal et al., 2003; Tenover et al., 2006). Additional
reports followed which demonstrated the widespread dis-
semination of USA300 across the USA (Begier et al., 2004;
Kazakova et al., 2005; Miller et al., 2005). Other than SSTI,
USA300 has also been reported as a causative agent of CA
pneumonia, sepsis, infective endocarditis and osteomyelitis
(Francis et al., 2005; Gonzalez et al., 2005; Haque et al.,
2007; Seybold et al., 2007). In addition to being responsible
for a rising incidence of CA infections, USA300 has also
been increasingly reported in association with nasal coloni-
sation (Freitas et al., 2010; Tenover et al., 2008) and HA
infections (Gonzalez et al., 2006; Patel et al., 2007; Seybold
et al., 2006). In the healthcare setting, USA300 was reported
to emerge alongside established HA-MRSA clones (Chua
et al., 2008; Limbago et al., 2009; Pasquale et al., 2013; Tat-
tevin et al., 2009) or to replace them (Carey et al., 2010; Liu
et al., 2008).
The striking epidemiology of USA300 within the USA
has prompted a number of genomic studies aimed at the
identification of genetic features that might have pro-
moted its transmission, host colonisation and disease
pathogenesis. Early whole-genome sequence analysis of a
single USA300 strain revealed that the accessory genome
included a Staphylococcal Cassette Chromosome mec
(SCCmec) type IVa element, an arginine catabolic mobile
element (ACME) type I, a S. aureus pathogenicity island
5 (SaPI5) and a Panton-Valentine leukocidin-carrying
fSa2 prophage (Diep et al., 2006). These four mobile
genetic elements (MGEs) represent common molecular
markers of USA300, although analysis of a wider popula-
tion demonstrated that their carriage is not ubiquitous
(Uhlemann et al., 2014). Isolates belonging to USA300
also frequently carry two plasmids: a 27 kb plasmid car-
rying genes that confer resistance to penicillin (blaZ),
erythromycin (msrA and mphBM) bacitracin (bcrA),
kanamycin (aphA-3) and streptothricin (sat), and a
3.1 kb cryptic plasmid (Kennedy et al., 2010). The con-
tribution of MGEs to the success of USA300 has been a
subject of debate and generation of the hypothesis that
the accessory genome has promoted the enhanced trans-
mission of USA300 (Li et al., 2009). In particular, the
ACME element has been suggested to promote the sur-
vival of USA300 on human skin and persistence within
cutaneous abscesses (Thurlow et al., 2013). In contrast,
the pathogenesis of USA300 may have been mediated by
subtle genetic changes within the core genome (High-
lander et al., 2007) together with modulated expression
of core virulence determinants such as a-toxin, phenol-
soluble modulins (PSMs) and an accessory gene regulator
(agr) (Li et al., 2009). Core genome single nucleotide
polymorphisms (SNPs) might also result in significantly
different virulence phenotypes between USA300 isolates,
associated with variable exoprotein expression (Kennedy
et al., 2008).
Recently, the genomics of USA300 have been studied on
a wider scale, through whole-genome sequencing of
larger collections derived from specific geographic
regions (Alam et al., 2015; Uhlemann et al., 2014). This
led to significant epidemiological findings such as the
Impact Statement
The expansion of Staphylococcus aureus USA300 and
its dominance as a community-associated MRSA
clone within the USA has prompted interest in the
genomics of this pathogen. The resolving power of
whole-genome sequencing has already shed light on
the nature of USA300 transmission within defined
communities. However, a question of the broader
population structure remains. Here, we investigated
whole-genome sequences of epidemiologically
diverse CC8 isolates, inclusive of 154 USA300 sam-
ples. Based on this collection we investigated the
wider population structure of USA300 and other
CC8 isolates and assessed temporal variation in core
and accessory genomes. We report that the USA300
population has become increasingly heterogeneous
between 2004 and 2010 at the core genome level,
accompanied by subtle changes in the accessory
genome involving loss of ACME and SCCmec ele-
ments and an increase in the prevalence of fSa5
prophage. These findings demonstrate that successful
lineages of MRSA are not genetically static and con-
tinue to evolve, which may involve loss of molecular
markers previously considered to define the lineage.
While further surveillance of USA300 genomes is
required to confirm wider SCCmec and ACME loss,
such genomic changes might impact on the future
epidemiology of this important S. aureus clone.
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identification of households as long-term reservoirs of
USA300. Comparative genomic analysis has also allowed
the diversification of the USA300 lineage to be studied,
including evolutionary events surrounding the emergence
of the USA300 clade as well as micro-evolution within
the population (Uhlemann et al., 2014). This exemplifies
the power of whole-genome sequencing for comprehen-
sive analysis of bacterial pathogens, as it allows an in-
depth interrogation of phylogenetic relationships, identi-
fication of genetic features associated with virulence and
antimicrobial resistance, and the reconstruction of signif-
icant evolutionary events (Harris et al., 2010; Holden
et al., 2013). While previous studies describing the com-
parative genomics of USA300 focused on
geographically restricted isolate collections, here we
describe whole-genome sequence analysis of S. aureus
CC8 derived from 12 USA healthcare centres located
across nine states. The isolates, collected in 2004, 2009
or 2010, were derived from the multi-centre Tigecycline
Evaluation and Surveillance Trial (T.E.S.T) study and
represent consecutive clinical isolates (methicillin-suscep-
tible and methicillin-resistant) from both the community
and hospital settings. As USA300 has become widespread
across the USA, an analysis of a collection from geo-
graphically distinct locations has allowed us to study a
broader population of epidemiologically unrelated
USA300 isolates as well as their microevolution over
time. For this we interrogated the phylogeny of the CC8
lineage, with particular focus on the USA300 clade,
followed by analysis of temporal variation within core
and accessory genomes as well as investigation of more
subtle polymorphisms that define the phylogenetic struc-
ture of the USA300 population.
Methods
Bacterial isolates. Isolates analysed here derived from the
Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), a
global multi-centre surveillance study. The trial was initiated
in 2004, and since then sites have been added and removed.
For the purpose of conducting a longitudinal assessment of
S. aureus isolates associated with disease in the USA, we pro-
spectively selected USA sites that were participating between
2004 and 2010 (five sites). A further seven sites active at the
time of study were included. A total of 516 S. aureus isolates
derived from 2004, 2009 and 2010 were collected and
analysed. All isolates belonging to CC8 (n = 191), as deter-
mined by multi-locus sequence typing, were selected for
this work.
In line with T.E.S.T requirements, the participating sites col-
lected consecutive isolates from patients with a documented
infection. Only one isolate per patient was permitted and all
body sites were considered an acceptable clinical source.
Epidemiological details of the 191 S. aureus CC8 isolates
analysed here are presented in Table S1 (available in the
online Supplementary Material). Briefly, isolates were
derived from the 12 T.E.S.T. sites that were located across
nine states of the USA (Fig. 1), with 26 % (50/191) collected
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Fig. 1. Geographic distribution of healthcare centres (HC) that collected isolates analysed in this study. The geographic location on the
map represents state coordinates, where the corresponding HC was based. Plots are scaled to represent total number of isolates from cor-
responding site. HCs that provided isolates used in temporal analyses are marked with a star.
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in 2004, 31 % (58/191) in 2009 and 43 % (83/191) in 2010.
For the purpose of this work the collecting sites were called
healthcare centre 1 – 12 (HC1 – HC12). The collection con-
sisted of 46 MSSA and 145 MRSA isolates. Isolates were col-
lected from diverse clinical sources, categorised in this work
to represent four main infection types defined as wound,
invasive, respiratory, or other. Isolates were collected from
patients aged 0 to 95 in various clinical settings, with sam-
ples broadly defined in this study as derived from either
inpatient or outpatient.
Whole-genome sequencing. Genomic DNA was isolated
using the Qiagen QIAcube system according to manufac-
turer’s protocol. Tagged DNA libraries were created using a
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Fig. 2. Midpoint-rooted phylogenetic tree of the 191 analysed S. aureus CC8 isolates. Four reference genomes were included (corre-
sponding nodes marked with a star). Branches of USA300, USA500 and USA500-like clades have been highlighted. The tree has been
annotated to show the association between phylogenetic distribution and healthcare centre (HC) of origin (excluding reference genomes),
year of collection (excluding reference genomes), patient type (excluding reference genomes), infection type (excluding reference genomes)
and carriage of mobile genetic elements (MGE). The latter shows the distribution of identified prophages, pathogenicity islands (where novel
sequence was identified, name has been assigned based on virulence gene content), transposons and other elements such as ICE6013
and dfrG insertion element, and plasmids (name assigned based on close similarity to previously identified plasmid). Further details on vari-
able carriage of virulence genes within fSa2 and fSa3 prophages, as well as variable distribution of antimicrobial resistance genes within
pUSA300HOUMR-like and pUSA03-like plasmids have been provided in Fig. S1. The tree was annotated using EvolView (Zhang et al.,
2012).
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method adapted from a standard Illumina Indexing
protocol, as described previously (Hsu et al., 2015). Whole-
genome sequencing was performed on the Illumina HiSeq
2000 platform with 100 bp paired-end reads. The Illumina
sequence data has been submitted to the European Nucleo-
tide Archive (ENA) and the accession numbers are provided
in Table S1.
Whole-genome sequence data analysis. Single nucleo-
tide polymorphisms (SNPs) were detected by mapping the
paired-end reads against the S. aureus USA300_FPR3757
reference genome (GenBank accession NC_007793), using
SMALT version 0.5.8. (http://www.sanger.ac.uk/science/
tools/smalt-0). The generated whole-genome sequence
alignment was curated to exclude accessory regions (mobile
genetic elements identified for USA300_FPR3757 reference
genome) and variable sites associated with recombination,
with the latter detected using Gubbins (Croucher et al.,
2014). Based on the curated core genome SNP alignment a
maximum-likelihood phylogenetic tree was reconstructed
using RAxML version 7.8.6 (Stamatakis, 2014) with the gen-
eralised time reversible (GTR) model with GAMMA
method of correction for among site rate variation and 100
bootstrap replications (Harris et al., 2010). De novo assem-
bly of whole-genome sequences was performed using Velvet
(Zerbino & Birney, 2008) with Velvet Optimiser (http://bio-
informatics.net.au/software.velvetoptimiser.shtml) and
kmers ranging between 66 % and 90 % of the read-length.
Contigs of less than 300 bp were removed. The draft assem-
blies have been submitted to the ENA with accession num-
bers provided in Table S1. The assembled contigs were
annotated using Prokka (Seemann, 2014). The accessory
genome was defined as described previously (Harris et al.,
2010).
Isolate genotyping. Multi-locus sequence typing was per-
formed on assembled genomes using an in-house developed
pipeline based on a previously described typing scheme
(Enright et al., 2000). Isolates were also spa genotyped by
extracting the spa gene variable X region from assembled
genomes using previously described primers (Kahl et al.,
2005), and determining the spa type with the spaTyper tool
(http://spatyper.fortinbras.us). MLST and spa genotypes of
all isolates are presented in Table S1. In addition, in silico
PCR was used to confirm carriage of prophages (Goerke
et al., 2009) and to determine the SCCmec type amongst
mecA-positive samples (Milheiriço et al., 2007a, b).
Statistical analyses. To test the statistical significance of
the temporal variation in the prevalence of USA300 isolates
as well as selected mobile genetic elements, the likelihood
ratio test was applied. The strength of phylogenetic signal of
epidemiological trait was measured using phylo.d() function
in R package caper based on 1000 permutations. The func-
tion computes a D value, which provides a measure of trait
dispersion for categorical characters (Fritz & Purvis, 2010).
A negative D statistic indicates that a trait is phylogenetically
clustered whereas a positive D statistic indicates that a trait
is over dispersed across the phylogenetic tree.
Results and Discussion
CC8 population structure overview and temporal
variation
Whole-genome sequences of 191 clinical S. aureus isolates
belonging to CC8 were analysed, the majority of which
belonged to ST8 (179/191, 94 %; Table S1). A total of ten
single-locus variants (SLV) of ST8 were identified, which
included six distinct novel STs. The majority of isolates
belonged to spa type t008 (146/191, 76 %; Table S1). Align-
ment of the core genomes (after excluding accessory regions
and regions of predicted recombination, resulting in a core
genome length of 2 592 236 bp) of all CC8 isolates revealed
a total of 10 651 SNP sites. To identify different sub-line-
ages, a phylogenetic tree of all CC8 samples was recon-
structed with the addition of USA300, USA500 and COL
reference genomes (Fig. 2). The tree revealed that the
majority of isolates belonged to a single dominant clade
(154/191, 81 %), which contained the two USA300 refer-
ence strains (USA300_FPR3757 and USA300-ISMMS1) and
thus was identified to represent the USA300 genotype. The
population also contained four isolates that clustered with
the USA500 reference strain (2395 USA500) and, as such,
represented the USA500 clone. Six further isolates were
closely related to the USA500 clade but descended from a
distinct node and were labelled here USA500-like. The
majority of these USA500 and USA500-like isolates (7/10)
originated from a single healthcare centre (HC10, state of
Georgia). The reconstructed phylogeny and detection of
USA300 and USA500 genotypes in the context of a diverse
CC8 population revealed that the two are only distantly
related, in contrast to a previous suggestion that USA500
represents a progenitor of the USA300 clone (Li et al.,
2009). A number of non-clonal MSSA CC8 isolates were
more closely related to the USA300 clade than the USA500
sub-lineage suggesting that the two MRSA clones arose
independently. The structure of CC8 phylogeny presented
here is in line with a recently published overview of evolu-
tionary relationships between various CC8 genomes (Boyle-
Vavra et al., 2015).
Isolates belonging to the USA300 clade were detected
amongst samples from all healthcare centres. Some geno-
typic heterogeneity was observed within the USA300 clade,
which contained six SLVs of ST8. We also observed a level
of spa type diversity amongst USA300 isolates. While the
majority belonged to spa type t008 (132/154, 86 %), 10
other spa types were identified, including t024 (8/154, 5 %)
and t681 (3/154, 2 %). The detected genotype diversity of
USA300 isolates based on multi- and single-locus genotyp-
ing underscores the benefit of applying core genome
sequence phylogeny for comprehensive identification of
clinically significant sub-lineages such as S. aureus USA300.
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Focusing on the USA300 clade only, we investigated the
strength of phylogenetic signal in the distribution of isolates
based on the healthcare centre of origin, year of isolation,
patient type and infection type. For this we calculated the D
statistic, which provides a measure of trait dispersion. A
random distribution of isolates based on geographic origin
was observed for the majority of healthcare centres (D range
0.17–1.22), with exception of HC1 (D =  0.68). Phyloge-
netic clustering was also observed for isolates collected in
2004 (D =  0.08) with random distribution of isolates
from 2009 and 2010 (D = 0.86 and D = 0.85, respectively).
No phylogenetic signal could be observed based on patient
type (outpatient, D = 0.73; inpatient, D = 0.91) or infection
type (wound, D = 0.48; respiratory, D = 0.67; invasive, D =
1.1).
We next investigated whether the CC8 population structure
and the distribution of USA300 genotype varied at different
sampling time points. For this, isolates collected in 2004
together with 2009 and 2010 collections derived from
matched healthcare centres were used (Fig. 1). We found
that USA300 was the dominant clone in all years. No signifi-
cant variation in the distribution of USA300 was observed
between 2004 (46/50, 92 %) and 2009 (23/24, 96 %) collec-
tions (p = 0.52). However, the 2010 collection (29/40,
73 %) revealed a significantly lower frequency of USA300
genotype in comparison with both 2004 (p < 0.05) and
2009 (p < 0.05). This suggests that the significant drop in
the prevalence of USA300 observed for 2010 was likely spe-
cific to that year rather than a time trend. Outside of the
USA300 clade, the USA500-like clone was observed only
amongst more recent samples with a single isolate identified
in 2009 (1/24, 4 %) and a comparatively higher prevalence
in 2010 (4/40, 10 %).
Accessory genome of CC8
The genomes of 191 S. aureus CC8 isolates were analysed
for the distribution of variable regions, followed by annota-
tion to define the accessory component. Overall, a diverse
mobile genetic repertoire was identified across the lineage,
although isolates belonging to USA300, USA500 and
USA500-like clones revealed the presence of clade-associ-
ated MGEs (Fig. 2).
In total, five different prophage types were identified. The
most common was fSa3, found in 96 % of isolates,
although variation in carriage of prophage-encoded viru-
lence factors was observed (Fig. S1). Nearly all fSa3-posi-
tive USA300 isolates carried the immune evasion cluster
(IEC) composed of scn, chp and sak genes, which was also
detected amongst some non-USA300 isolates. The second
most common prophage, due to the dominance of USA300
within this population, was fSa2. All but one USA300 iso-
late carried the Panton-Valentine leukocidin-positive
fSa2USA300, which was also detected in three non-
USA300 isolates. Three further prophages were identified
within the analysed CC8 population: fSa1, fSa5 and fSa7.
All three were detected at considerably lower frequency
than fSa3 or fSa2. Prophage fSa1 was detected sporadi-
cally but across the entire CC8 population, whereas fSa7
was prevalent mostly amongst non-USA300 MRSA isolates
and found in all USA500 and the majority of USA500-like
(5/6) samples. In contrast, prophage fSa5 was identified
predominantly within the USA300 clade (47/154, 30 %),
and was randomly distributed (D = 1.66) across the
USA300 phylogeny suggesting multiple acquisition events
rather than prevalence due to clonal propagation of fSa5-
positive isolates. No putative virulence genes were identified
within the sequence of any of the three prophages. We
investigated whether acquisition of these prophages might
affect the bacterial host thorough gene inactivation at the
insertion site. Analysis of the chromosomal environment
surrounding the site of prophage insertion revealed that
fSa1 and fSa7 inserted within intergenic locations down-
stream of the iron-sulphur cluster assembly protein
gene sufB (between coding sequences corresponding to
USA300_FPR3757 SAUSA300_0822 and SAUSA300_0823),
and the heme transport protein gene isdB (between
coding sequences corresponding to USA300_FPR3757
SAUSA300_1027 and SAUSA300_1028), respectively. In
contrast, prophage fSa5 were found inserted within a cod-
ing sequence responsible for a putative metal-binding pro-
tein with iron-sulphur oxidoreductase domain
(SAUSA300_1858), which would likely interfere with its
expression.
Other accessory virulence genes amongst analysed CC8 iso-
lates were associated with various pathogenicity islands,
with SaPI5 identified in majority of USA300 isolates (139/
154, 90 %). Nearly all USA500 (3/4) and USA500-like (5/6)
isolates carried the SaPI3, which similarly to SaPI5, encodes
the seK and seQ enterotoxin genes.
The majority of USA300 isolates carried ACME (137/154,
89 %) and SCCmec type IVa elements (130/154, 84 %),
which were not found in any other isolates. Where the ele-
ments were absent this was predicted to have resulted from
a deletion event, with corresponding isolates dispersed
across the phylogenetic tree. In line with a previous report
(Uhlemann et al., 2014), an association between the absence
of SCCmec and ACME was observed, with majority of
ACME-negative USA300 isolates also lacking the SCCmec
(13/17, 76 %). This is not surprising considering the proxi-
mal location of these elements in the USA300 chromosome.
Nearly all SCCmec-positive USA300 isolates carried a com-
plete type IVa element although two isolates carried unusual
recombinant variants of SCCmec IVa, which arose through
putative recombination of SCCmec with ACME or another
SCCmec element (Fig. S2). We also identified one isolate
carrying a remnant SCC element lacking the mecA gene that
exhibited similarity to SCCpbp4 from Staphylococcus epider-
midis ATCC 12228. Finally, non-USA300 mecA-positive iso-
lates carried either SCCmec IVd or SCCmec IVg. The
carriage of SCCmec correlated with the methicillin suscepti-
bility phenotype (Table S1) except for a single SCCmec-pos-
itive isolate, which was identified as MSSA (PFESA2067).
Further investigation revealed the presence of a single base
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insertion in mecA gene resulting in a frame-shift mutation
and premature stop codon, which would likely lead to a loss
of mecA expression.
The analysed CC8 population revealed a high prevalence of
an accessory region recognised as integrative conjugative
element 6013 (ICE6013) (Smyth & Robinson, 2009). The
element was detected in all USA300 and USA500 isolates
but was absent in all USA500-like samples. The ICE6013
does not appear to carry any specific virulence or resistance
genes and lacks insertion specificity (Smyth & Robinson,
2009), integrating at a number of sites amongst the analysed
CC8 isolates, including both inter- and intragenic positions
(Fig. S3). In the USA300 isolates however, ICE6013 was
only found inserted within a putative membrane protein
gene (SAUSA300_0606), and thus an insertional inactiva-
tion of this particular coding sequence might provide selec-
tive advantage to USA300. Interestingly, this particular
ICE6013 insertion site differs from the USA300_FPR3757
reference genome (Diep et al., 2006), which also contains
this element, but is identical to ICE6013 location within the
USA300-ISMMS1 genome (Altman et al., 2014).
There was only a sporadic carriage of resistance-associated
transposon elements such as tetM-positive Tn6086, ermA-
and spc-positive Tn554, and bla operon-carrying Tn552. All
USA500-like isolates carried a 3.3 kb insertion element con-
taining the trimethoprim resistance gene dfrG, not found
elsewhere in this collection. Amongst USA300 isolates, the
antimicrobial resistance genes were carried predominantly
on plasmids, with the majority of samples (146/154, 95 %)
carrying a large plasmid resembling a previously reported
27 kb pUSA300HOUMR (Highlander et al., 2007). The
plasmid contains genes that confer resistance to various
antimicrobials including penicillin (blaZ), kanamycin
(aphA-3), streptothricin (sat), bacitracin (bcrA) and erythro-
mycin (msrA, mphBM), and homologous plasmids have
been previously reported in other USA300 isolates
(Kennedy et al., 2010; Uhlemann et al., 2014). However,
amongst the 146 USA300 isolates carrying the pUSA300-
HOUMR-like plasmid, 12 carried a variant that lacked
some of the resistance genes described above, with at least
five different variants detected (Fig. S1). The pUSA300-
HOUMR-like plasmid was not confined to the USA300
clade within this collection, and was detected in several
other isolates. A few USA300 isolates (8/154, 5 %) carried a
circa 34 kb plasmid, which partly resembled the 37 kb
pUSA03 that contains genes conferring resistance to eryth-
romycin (ermC) and mupirocin (ileS-2) (Diep et al., 2006).
At least three variants of this pUSA03-like plasmid were
observed (Fig. S1). All lacked the ermC gene, and only some
carried the ileS-2 resistance determinant. In addition some
of the ileS-2-positive variants also carried the kanamycin
resistance gene addD. Also detected amongst USA300 iso-
lates (3/154, 2 %) was a 2.5 kb ermC-positive pWBG751-
like plasmid and a small tetracycline resistance (tetK) plas-
mid (8/154, 5 %), resembling the 4.4 kb pUSA02 (Diep
et al., 2006).
Temporal variation in the accessory genome
We further analysed whether the variable distribution of
selected MGEs was associated with the year of sampling. For
this, we compared the distribution of SCCmec, ACME and
fSa5 amongst USA300 isolates collected in 2004 with the
2009 and 2010 collections from matched healthcare centres
(Table 1). All USA300 isolates carried SCCmec in 2004, with
a single negative isolate in 2009. The frequency of SCCmec
carriage was lowest amongst 2010 isolates, which repre-
sented a significant drop in comparison with both 2004 (p
Table 1. Temporal variation in the distribution of selected mobile genetic elements among USA300 isolates. Based on isolates
derived from healthcare centres selected for temporal analysis (HC1, HC6, HC7, HC10)
2004 2009 2010
N* SCCmec ACME FSa5 N* SCCmec ACME FSa5 N* SCCmec ACME FSa5
HC1 14 14 14 2 na na na na 8 6 7 5
HC6 6 6 6 1 12 12 12 4 8 7 7 3
HC7 8 8 8 3 10 9 8 2 5 2 4 3
HC10 18 18 18 2 1 1 1 0 8 6 6 3
Total 46 46 46 8 23 22 21 6 29 21 24 14
p† 0.19 <0.05 0.7
p‡ <0.05 <0.05 <0.05
p§ <0.05 0.39 0.07
*Total number of USA300 isolates identified for corresponding centre and year.
†p value after controlling for each HC, for the distribution of corresponding MGE among USA300 isolates in 2004 and 2009.
‡p value after controlling for each HC, for the distribution of corresponding MGE among USA300 isolates in 2004 and 2010.
§p value after controlling for each HC, for the distribution of corresponding MGE among USA300 isolates in 2009 and 2010.
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< 0.05) and 2009 (p < 0.05) groups. Emergence of SCCmec-
negative USA300 isolates resulting from a sporadic loss of
the element has been previously reported, however at lower
frequency than observed here (Uhlemann et al., 2014). As
such the reduced frequency of SCCmec amongst USA300
isolates from 2010 might be specific to that year. Neverthe-
less a reported shift in antimicrobial prescription practices
in the US between 2004 and 2008, away from b-lactams in
favour of MRSA-active drugs when treating SSTI might
have influenced the epidemiology of CA-MRSA infections
(Talan et al., 2011). Lower frequency of beta-lactam usage
could result in a lower selective pressure to maintain
SCCmec leading to gradual loss of this element. While
USA300 has been recognised predominantly as an MRSA
lineage, infections caused by MSSA USA300 have also been
reported suggesting that transmission of USA300 may not
be entirely dependent on SCCmec carriage (McCaskill et al.,
2007; Talan et al., 2011). In support of the hypothesis that a
shift in epidemiology of MRSA might have occurred around
2010, we also observed an increase in the prevalence of
non-USA300 SCCmec-negative isolates at this sampling
time point.
As described above, carriage of ACME was associated with
the distribution of SCCmec amongst USA300 isolates.
Therefore in line with SCCmec prevalence, loss of ACME
was only observed in 2009 and 2010 samples, both groups
showing a significantly lower number of ACME-positive
USA300 isolates when contrasted with the 2004 group (p <
0.05). Although the prevalence of ACME-negative USA300
isolates was more notable in 2010, the difference between
2009 and 2010 was not significant (p = 0.39).
The sample size of our collection was relatively low and
thus the observed temporal variation in the distribution of
SCCmec and ACME among USA300 isolates, and the appar-
ent loss of these elements in more recent samples, would
require further surveillance. However, the occurrence of
SCCmec-negative and ACME-negative USA300 isolates was
not limited to a particular healthcare centre (Table 1). Fur-
thermore, the absence of phylogenetic association between
USA300 isolates lacking either SCCmec or ACME suggests
that forces driving the loss of these important MGEs are act-
ing upon the wider USA300 population.
In addition to changes in prevalence of SCCmec and ACME,
we observed a trend of increasing prophage fSa5 frequency,
although only the difference between 2004 and 2010 isolates
was statistically significant (p < 0.05). The overall frequency
of fSa5 carriage by USA300 isolates collected in 2009 and
2010 was higher than the prevalence reported for New York
City isolates (16 %) (Uhlemann et al., 2014). However, the
presence of fSa5 prophage within the latter collection was
associated with a particular USA300 sub-clade, suggesting
that carriage of this prophage might contribute to expansion
of more successful sub-populations (Uhlemann et al.,
2014).
The USA300 population analysed in this study demon-
strated a stable temporal prevalence of antimicrobial
resistance-associated MGEs. All isolates collected in 2004
carried the multiple drug resistance pUSA300HOUMR-like
plasmid, which was also found in the majority of 2009 (20/
23, 87 %) and 2010 isolates (28/29, 97 %) from matched
healthcare centres. A dip in pUSA300HOUMR-like plasmid
prevalence amongst 2009 isolates was specific to a single
centre and thus unlikely to represent a wider trend. It has
been previously observed that carriage of aminoglycoside-
and bacitracin-resistance genes associated with the
pUSA300HOUMR-like plasmid might mediate resistance to
certain topical antimicrobial agents available over-the-
counter in the USA (Suzuki et al., 2011). It is likely, there-
fore, that a continuous selective pressure has been maintain-
ing this element within the USA300 population.
We also investigated whether the chromosomally-inserted
MGEs carried by USA300 (fSa2, fSa3, SaPI5, ACME,
SCCmec IVa and ICE6013) diversified over time leading to
temporal variation in the distribution of pairwise SNP dis-
tances. To discount recombination-mediated variation,
alignments of each MGE sequence were first queried for the
presence of recombination regions and if detected, the cor-
responding isolate was removed from the analysis (up to
two isolates for ICE6013, fSa3 and SCCmec IVa were
removed). We found that the analysed MGEs were well
conserved between the isolates, with a median pairwise SNP
distance for all elements equal to 1. When comparing the
median of pairwise SNP distances for individual MGEs
between the 2004, 2009 and 2010 isolates, temporal varia-
tion was observed for all except ACME and ICE6013
elements (Fig. 3). For all, an increase of median pairwise
SNP distance by 1 was observed at either or both later sam-
pling time points.
Outside the USA300 clade, it was noteworthy that the tem-
porally distributed USA500-like sub-population differed
markedly in its accessory genome from the closely related
USA500 clone and could be distinguished based on SCCmec
type, carriage of dfrG insertion element and absence of the
ICE6013.
Core genome microevolution of USA300 clade
We investigated further the core genomes of USA300
isolates and found that the population formed a hetero-
geneous clade with a median pairwise SNP distance of
88 and a range of 0–165 SNPs. We then investigated if
USA300 population has become more heterogeneous
over time by comparing pairwise SNP distances of iso-
lates collected in 2004 with the panels from 2009 and
2010 (isolates from matched healthcare centres only).
We observed an increase in median pairwise SNP dis-
tance values between 2004 [62, median absolute devia-
tion (MAD) = 13] and 2009 (103, MAD = 13) as well
as 2010 (98, MAD = 15) groups. As previously reported
(Kennedy et al., 2008), the USA300 isolates demonstrate
an elevated ratio of non-synonymous-to-synonymous
SNPs (dN/dS), associated with the recent clonal expan-
sion of this lineage and accumulation of SNPs that have
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not yet been eliminated by purifying selection (Rocha
et al., 2006). We observed a dN/dS median of 0.71
(MAD = 0.19) across USA300 core genomes, in com-
parison to the median 0.22 (MAD = 0.01) dN/dS ratio
for non-USA300 isolates. In order to determine the dN/
dS ratio of mutations that were acquired independently
by the USA300 isolates after each diverged from the last
common ancestor, we determined the dN/dS ratios on
terminal branches of the USA300 clade. For clonal or
very closely related isolates (up to 2 pairwise SNPs dis-
tance) a single representative was selected, and isolates
that accumulated less than a total of 10 SNPs since
divergence from the last common ancestor, or showed
either no synonymous or no non-synonymous mutations
were excluded. A total of 139 USA300 isolates were ana-
lysed and revealed a median dN/dS ratio of 2.6 (MAD
= 1.1), which corresponded to a previously reported
dN/dS ratio for another USA300 collection (Kennedy
et al., 2008). Analysis of temporal changes in dN/dS
ratio revealed equally high median values for 2004 (2.33,
MAD = 1.23), 2009 (2.5, MAD = 0.4) and 2010 (2.8,
MAD = 1.5) altogether indicating that purifying selection
has not yet acted upon the USA300 population (Rocha
et al., 2006).
To interrogate more closely the phylogenetic structure of
the USA300 clade, we repeated the phylogeny recon-
struction for USA300 isolates only (Fig. 4). Genomic
divergence within the USA300 clade, based on branch
lengths, was most pronounced on terminal branches and
thus was strain-specific. In line with previous studies
describing the population structure of USA300 isolates,
the generated phylogeny revealed low resolution of inter-
strain evolutionary relationships due to short internal
branches. We therefore investigated further the clustering
patterns of the innermost branches descending immedi-
ately from the root of USA300 clade, by focusing on
branches that after each evolutionary split gave rise to a
majority of the descending population. This revealed a
subtle and sequential diversification process involving the
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Fig. 3. Temporal variation in pairwise SNP distance distributions between chromosomally-inserted MGEs carried by USA300 isolates.
Based on isolates derived from healthcare centres selected for temporal analysis (HC1, HC6, HC7, HC10).
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formation of nested clades (Fig. 4). Based on the collec-
tion analysed in this study, at least six fine-scale diver-
gence events descending from the root of the clade
could be identified, each involving acquisition of up to
five SNPs (Table 2). Where branches emerged due to
multiple SNPs, in each case the mutations were inde-
pendent in relation to their genomic position and thus
did not represent a recombination. Nearly all mutations
occurring in protein-coding sequence were non-synony-
mous (11/12) and involved genes of various functions.
Four of the non-synonymous SNPs occurring across
three distinct branches were identified in genes associ-
ated with antimicrobial resistance. This included a gene
encoding a putative drug resistance transporter ErmB/
QacA (SAUSA300_2126), a gene encoding an efflux
pump (SAUSA300_2489) recently associated with resis-
tance to linoleic and arachidonic acids that are present
on the skin and contribute to the low pH of this envi-
ronment (Alnaseri et al., 2015), and the genes gyrA
(SAUSA300_006) and parC/grlA (SAUSA300_1251)
associated with fluoroquinolone resistance. The emer-
gence of fluoroquinolone resistance in the USA300 pop-
ulation was previously described and estimated to have
occurred around 1995 (Uhlemann et al., 2014). Amongst
other genes affected by non-synonymous SNPs was a
putative virulence determinant (SAUSA300_1322), which
belongs to the cvfC operon and contributes to control
of haemolysin production and detergent resistance
through positive regulation of thyA gene (Ikuo et al.,
2010).
To further resolve the observed USA300 tree topology and
formation of nested clades, we have reconstructed the phy-
logeny of the studied USA300 isolates together with 329
genomes of previously sequenced USA300 isolates derived
from New York city (Uhlemann et al., 2014). The tree
topology of this expanded USA300 collection also revealed a
nested clade population structure (Fig. S4). The clade-defin-
ing mutations corresponded to the polymorphisms
described above (Table 2) demonstrating that the early
1 
2 
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4 
5 
6 
Reference genom es
0.003 substitutions/site  
USA300_ISMMS1
USA300_FPR3757
Fig. 4. Mid-point rooted phylogenetic tree of S. aureus USA300 isolates. Two most closely related non-USA300 isolates were included
as an out-group (isolates PFESA2332 and PFESA1492, red branches). Also, two reference genomes were included and corresponding
nodes are marked with a star. Branches were highlighted to show consecutive clades of the nested clade structure, and labelled 1 to 6.
SNPs that define each labelled clade are described in Table 2.
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diversification changes identified in this work can be
detected across wider USA300 population.
Conclusions
This study provides an overview of the S. aureus CC8 popu-
lation structure based on whole-genome sequence analysis
of clinical isolates derived from nine USA states, collected in
2004, 2009 and 2010. Unsurprisingly, it was dominated by
the USA300 clone. The non-USA300 isolates represented a
fifth of the CC8 population and included the USA500 clone
as well as a closely related USA500-like genotype with a dis-
tinct accessory genome composition, which emerged at the
later sampling time point. The USA500 clone emerged prior
to the appearance and dissemination of the USA300 geno-
type but has been diminishing in prevalence since (David
et al., 2015; Nelson et al., 2015). This trend was also
observed in our collection, with the majority of USA500 iso-
lates identified amongst the 2004 samples. Furthermore, the
distribution of both USA500 and USA500-like isolates was
geographically restricted as most originated from a single
site (HC10). This is in contrast to geographically dispersed
USA300 isolates. There may also be additional regional dif-
ferences associated with USA500 that we did not detect
owing to the majority of USA500 isolates being detected
from just one site. For example, Benson et al. (2014) identi-
fied that most of the USA500 isolates obtained from patients
in New York area harboured the IS256 element located in
close proximity to the rot gene. In our analysis we identified
the presence of this IS element in the genomes of all
USA500 isolates and a single USA500-like strain. However,
insertion of IS256 next to rot was observed for only one of
the USA500 strains.
The analysis of temporal variation in the population struc-
ture of CC8 isolates indicated a significant drop in the prev-
alence of USA300 around 2010, in comparison with both
2004 and 2009. However, due to the limitations of our study
such as narrow sampling time points, small sample size and
lack of isolates representing the Western USA we could not
verify if this dip in frequency of USA300 clone represented a
broader event or a time trend. A recent review reported that
there has been an overall increase in spatio-temporal preva-
lence of USA300 across the USA between 2000 and 2013 in
the context of MRSA epidemiology (Carrel et al., 2015).
However, regional differences as well as year-on-year fluctu-
ations were also observed, demonstrating a need for a
national surveillance program that would allow more accu-
rate monitoring of the epidemiology of clinically significant
S. aureus clones such as USA300.
Based on this geographically diverse collection of CC8 iso-
lates, we investigated the USA300 clade for evidence of
microevolution. The observed limited phylogeographic clus-
tering suggests a general lack of geographical expansion
events resulting from emergence of locally adapted clones.
This is in agreement with findings that at a local community
level, multiple introductions of USA300 occur (Uhlemann
et al., 2014). Analysis of core genomes revealed that USA300
isolates are becoming more heterogeneous as defined by a
temporal increase in pairwise SNP distances, which is
Table 2. Descriptive summary of SNPs identified on branches of early divergence nested clades across the phylogenetic tree of
analysed USA300 isolates. The phylogeny is presented in Fig. 4
Clade FPR3757
Position
SNP
Type*
CDS ID Product Base
change
AA
change
1 2300219 NS SAUSA300_2126 drug resistance transporter, EmrB/QacA
subfamily
A -> G V156A
2 150941 NS SAUSA300_0132 glycosyl transferase T -> A D271E
714167 I     A -> G  
1453525 NS SAUSA300_1322 virulence factor C, CvfC3 G -> A A281V
1877205 NS SAUSA300_1701 NAD(FAD)-utilizing dehydrogenase G -> A R228H
1915352 I     A -> G  
3 386867 I     A -> T  
4 906507 I     C -> A  
1693739 NS SAUSA300_1543 oxygen-independent coproporphyrinogen III
oxidase
C -> T A145T
1908169 NS SAUSA300_1725 transaldolase C -> T V6I
2230768 S SAUSA300_2068 hypothetical protein T -> C  
2690087 NS SAUSA300_2489 antibiotic transport-associated protein G -> T Q795K
5 7282 NS SAUSA300_0006 DNA gyrase GyrA C -> T S84L
1374405 NS SAUSA300_1251 DNA topoisomerase ParC/GrlA C -> A S80Y
6 837108 NS SAUSA300_0750 hypothetical protein T -> G D17E
1074815 NS SAUSA300_0980 putative membrane protein A -> G N71D
* SNP type: NS – non-synonymous; I – intergenic; S – synonymou.
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underlined by a stable pattern of elevated dN/dS ratios.
However, an analysis of the wider phylogenetic relationships
defined by branches descending immediately from the root
of the clade revealed the presence of subtle polymorphisms
shared across the population. The pattern of accumulative
SNP acquisition as defined by the formation of nested
clades suggests that the USA300 ancestral isolates continued
to diversify shortly after the emergence of the clade but
prior to its clonal expansion. Although determining the
phenotypic significance of the acquired SNPs is beyond the
scope of this work, we speculate that at least some might
represent adaptive evolution such as development of anti-
microbial resistance.
Our data also suggests temporal changes in the composition
of the USA300 accessory genome involving small-scale loss
of SCCmec and ACME elements and increased frequency of
fSa5 carriage. These findings are subject to the previously
described limitations of this study and thus might not be
indicative of a continuous temporal trend of USA300 acces-
sory genome re-shuffle. Still, the collection analysed in this
study represents an unbiased sample of S. aureus CC8 popu-
lation derived from diverse clinical sources, providing a
unique insight into the broader epidemiology and evolution
of USA300 in the context of its parental lineage. This
allowed us to capture the apparent instability of SCCmec
and ACME carriage amongst more recent USA300 isolates.
This is significant considering some strategies for identifica-
tion of USA300 isolates based on defined genetic markers
such as carriage of SCCmec or ACME (Alam et al., 2015;
David et al., 2013), which might hinder identification of
emerging USA300 variants that have lost these MGEs lead-
ing to their under-reporting. Also, taking into consideration
the putative role of SCCmec and ACME in the successful
dissemination of S. aureus USA300, it will be important to
understand what leads to the loss of these elements. We
speculate that the loss of SCCmec may have been driven by
changes in antimicrobial prescription practices in the USA.
It is more challenging to hypothesize what factors could
have contributed to the drop in ACME prevalence. How-
ever, the observation that absence of SCCmec and ACME
coincided in majority of isolates, suggests that the elements
are frequently lost in a single deletion event. This scenario is
supported by previous findings that the CcrAB recombi-
nases of SCCmec can mobilise ACME as well as catalyse an
excision of the entire ACME– SCCmec composite island
(Diep et al., 2008). While further work is required to inves-
tigate how this might impact on the epidemiology of
USA300, the analysis presented here of spatially diverse
USA300 isolates gives a new insight into the wider evolu-
tionary changes occurring within this highly successful sub-
lineage, and provides ground for further surveillance of this
clone.
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